Abstract
Purpose
To assess the role of pretreatment multiparametric (mp)MRI-based radiomic features in predicting pathologic complete response (pCR) of locally advanced rectal cancer (LARC) to neoadjuvant chemoradiation therapy (nCRT).
Methods
This was a retrospective dual-center study including 98 patients (M/F 77/21, mean age 60 years) with LARC who underwent pretreatment mpMRI followed by nCRT and total mesorectal excision or watch and wait. Fifty-eight patients from institution 1 constituted the training set and 40 from institution 2 the validation set. Manual segmentation using volumes of interest was performed on T1WI pre-/post-contrast, T2WI and diffusion-weighted imaging (DWI) sequences. Demographic information and serum carcinoembryonic antigen (CEA) levels were collected. Shape, 1st and 2nd order radiomic features were extracted and entered in models based on principal component analysis used to predict pCR. The best model was obtained using a k-fold cross-validation method on the training set, and AUC, sensitivity and specificity for prediction of pCR were calculated on the validation set.
Results
Stage distribution was T3 (n = 79) or T4 (n = 19). Overall, 16 (16.3%) patients achieved pCR. Demographics, MRI TNM stage, and CEA were not predictive of pCR (p range 0.59–0.96), while several radiomic models achieved high diagnostic performance for prediction of pCR (in the validation set), with AUCs ranging from 0.7 to 0.9, with the best model based on high b-value DWI demonstrating AUC of 0.9 [95% confidence intervals: 0.67, 1], sensitivity of 100% [100%, 100%], and specificity of 81% [66%, 96%].
Conclusion
Radiomic models obtained from pre-treatment MRI show good to excellent performance for the prediction of pCR in patients with LARC, superior to clinical parameters and CEA. A larger study is needed for confirmation of these results.
Graphical abstract
Similar content being viewed by others
Data availability
Codes used to obtain radiomic models are available upon request.
Abbreviations
- DWI:
-
Diffusion-weighted imaging
- LARC:
-
Locally advanced rectal cancer
- MLP:
-
Multilayer perceptron
- mpMRI:
-
Multiparametric magnetic resonance imaging
- nCRT:
-
Neoadjuvant chemoradiation therapy
- PCA:
-
Principal component analysis
- pCR:
-
Pathologic complete response
- T1WI:
-
T1-weighted imaging
- T2WI:
-
T2-weighted imaging
- TRG:
-
Tumor regression grade
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68 (6):394–424. https://doi.org/10.3322/caac.21492
Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising Proportion of Young Individuals With Rectal and Colon Cancer. Clin Colorectal Cancer 18 (1):e87–e95. https://doi.org/10.1016/j.clcc.2018.10.002
Benson AB, III, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA (2018) Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16 (7):874–901. https://doi.org/10.6004/jnccn.2018.0061
Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo L-J, Calvo FA, García-Aguilar J, Glynne-Jones R, Haustermans K, Mohiuddin M, Pucciarelli S, Small W, Jr., Suárez J, Theodoropoulos G, Biondo S, Beets-Tan RGH, Beets GL (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. The Lancet Oncology 11 (9):835–844. https://doi.org/10.1016/S1470-2045(10)70172-8
Maas M, Lambregts DMJ, Nelemans PJ, Heijnen LA, Martens MH, Leijtens JWA, Sosef M, Hulsewé KWE, Hoff C, Breukink SO, Stassen L, Beets-Tan RGH, Beets GL (2015) Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Annals of Surgical Oncology 22 (12):3873–3880. https://doi.org/10.1245/s10434-015-4687-9
Vliegen RFA, Beets GL, Meyenfeldt MFv, Kessels AGH, Lemaire EEMT, Engelshoven JMAv, Beets-Tan RGH (2005) Rectal Cancer: MR Imaging in Local Staging—Is Gadolinium-based Contrast Material Helpful? 234 (1):179–188. https://doi.org/10.1148/radiol.2341031403
Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: Images Are More than Pictures, They Are Data. Radiology 278 (2):563–577. https://doi.org/10.1148/radiol.2015151169
Petkovska I, Tixier F, Ortiz EJ, Golia Pernicka JS, Paroder V, Bates DD, Horvat N, Fuqua J, Schilsky J, Gollub MJ, Garcia-Aguilar J, Veeraraghavan H (2020) Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy. Abdominal Radiology. https://doi.org/10.1007/s00261-020-02502-w
Shaish H, Aukerman A, Vanguri R, Spinelli A, Armenta P, Jambawalikar S, Makkar J, Bentley-Hibbert S, Del Portillo A, Kiran R, Monti L, Bonifacio C, Kirienko M, Gardner KL, Schwartz L, Keller D (2020) Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study. European Radiology 30 (11):6263–6273. https://doi.org/10.1007/s00330-020-06968-6
Antunes JT, Ofshteyn A, Bera K, Wang EY, Brady JT, Willis JE, Friedman KA, Marderstein EL, Kalady MF, Stein SL, Purysko AS, Paspulati R, Gollamudi J, Madabhushi A, Viswanath SE (2020) Radiomic Features of Primary Rectal Cancers on Baseline T2-Weighted MRI Are Associated With Pathologic Complete Response to Neoadjuvant Chemoradiation: A Multisite Study. Journal of Magnetic Resonance Imaging n/a (n/a). https://doi.org/10.1002/jmri.27140
van Griethuysen JJM, Lambregts DMJ, Trebeschi S, Lahaye MJ, Bakers FCH, Vliegen RFA, Beets GL, Aerts HJWL, Beets-Tan RGH (2020) Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer. Abdominal Radiology 45 (3):632–643. https://doi.org/10.1007/s00261-019-02321-8
Nie K, Shi L, Chen Q, Hu X, Jabbour SK, Yue N, Niu T, Sun X (2016) Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI. J Clinical Cancer Research 22 (21):5256–5264. https://doi.org/10.1158/1078-0432.CCR-15-2997%
Cui Y, Yang X, Shi Z, Yang Z, Du X, Zhao Z, Cheng X (2019) Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 29 (3):1211–1220. https://doi.org/10.1007/s00330-018-5683-9
Cheng Y, Luo Y, Hu Y, Zhang Z, Wang X, Yu Q, Liu G, Cui E, Yu T, Jiang X (2021) Multiparametric MRI-based Radiomics approaches on predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer. Abdom Radiol (NY) 46 (11):5072–5085. https://doi.org/10.1007/s00261-021-03219-0
Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G (2013) The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the “DISTANCE”? Radiology 268 (2):330–344. https://doi.org/10.1148/radiol.13121361
Edge SB BD, Compton CC, Fritz AG, Greene FL, Trotti A. (2010) AJCC cancer staging manual. 7th edn. Springer-Verlag, New York
Zwanenburg A, Vallieres M, Abdalah MA, Aerts H, Andrearczyk V, Apte A, Ashrafinia S, Bakas S, Beukinga RJ, Boellaard R, Bogowicz M, Boldrini L, Buvat I, Cook GJR, Davatzikos C, Depeursinge A, Desseroit MC, Dinapoli N, Dinh CV, Echegaray S, El Naqa I, Fedorov AY, Gatta R, Gillies RJ, Goh V, Gotz M, Guckenberger M, Ha SM, Hatt M, Isensee F, Lambin P, Leger S, Leijenaar RTH, Lenkowicz J, Lippert F, Losnegard A, Maier-Hein KH, Morin O, Muller H, Napel S, Nioche C, Orlhac F, Pati S, Pfaehler EAG, Rahmim A, Rao AUK, Scherer J, Siddique MM, Sijtsema NM, Socarras Fernandez J, Spezi E, Steenbakkers R, Tanadini-Lang S, Thorwarth D, Troost EGC, Upadhaya T, Valentini V, van Dijk LV, van Griethuysen J, van Velden FHP, Whybra P, Richter C, Lock S (2020) The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology 295 (2):328–338. https://doi.org/10.1148/radiol.2020191145
Bianchini L, Botta F, Origgi D, Rizzo S, Mariani M, Summers P, García-Polo P, Cremonesi M, Lascialfari A (2020) PETER PHAN: An MRI phantom for the optimisation of radiomic studies of the female pelvis. Phys Med 71:71–81. https://doi.org/10.1016/j.ejmp.2020.02.003
Agliari E, Alemanno F, Barra A, De Marzo G (2022) The emergence of a concept in shallow neural networks. Neural Netw 148:232–253. https://doi.org/10.1016/j.neunet.2022.01.017
Almeida LBJHoNCC (1997) C1. 2 Multilayer perceptrons. 1
Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP (2002) SMOTE: synthetic minority over-sampling technique. Journal of Artificial Intelligence Research 16:321–357
Breiman L (2001) Random Forests. Machine Learning 45 (1):5–32
Lambregts DM, Maas M, Bakers FC, Cappendijk VC, Lammering G, Beets GL, Beets-Tan RG (2011) Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy. Dis Colon Rectum 54 (12):1521–1528. https://doi.org/10.1097/DCR.0b013e318232da89
Shin J, Seo N, Baek SE, Son NH, Lim JS, Kim NK, Koom WS, Kim S (2022) MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy. Radiology 303 (2):351–358. https://doi.org/10.1148/radiol.211986
Cusumano D, Dinapoli N, Boldrini L, Chiloiro G, Gatta R, Masciocchi C, Lenkowicz J, Casà C, Damiani A, Azario L, Van Soest J, Dekker A, Lambin P, De Spirito M, Valentini V (2018) Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer. Radiol Med 123 (4):286–295. https://doi.org/10.1007/s11547-017-0838-3
Kelly RJ, Bever K, Chao J, Ciombor KK, Eng C, Fakih M, Goyal L, Hubbard J, Iyer R, Kemberling HT, Krishnamurthi S, Ku G, Mordecai MM, Morris VK, II, Paulson AS, Peterson V, Shah MA, Le DT (2023) Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. J Immunother Cancer https://doi.org/10.1136/jitc-2022-006658
Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, Khanduja KS (2002) T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45 (7):895–903. https://doi.org/10.1007/s10350-004-6325-7
Jalilian M, Davis S, Mohebbi M, Sugamaran B, Porter IW, Bell S, Warrier SK, Wale R (2016) Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome. J Gastrointest Oncol 7 (4):603–608. https://doi.org/10.21037/jgo.2016.05.03
Park J-S, Baek J-H, Lee W-S, Yang J-Y, Lee W-K, Kim K-K, Park Y-H (2018) Long-term oncologic outcomes in pathologic tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer. Korean J Clin Oncol 14 (1):37–42. https://doi.org/10.14216/kjco.18006
Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nature Communications 5 (1):4006. https://doi.org/10.1038/ncomms5006
Bobo MF, Bao S, Huo Y, Yao Y, Virostko J, Plassard AJ, Lyu I, Assad A, Abramson RG, Hilmes MA, Landman BA (2018) Fully Convolutional Neural Networks Improve Abdominal Organ Segmentation. Proceedings of SPIE—the International Society for Optical Engineering 10574:105742V. https://doi.org/10.1117/12.2293751
Traverso A, Kazmierski M, Shi Z, Kalendralis P, Welch M, Nissen HD, Jaffray D, Dekker A, Wee L (2019) Stability of radiomic features of apparent diffusion coefficient (ADC) maps for locally advanced rectal cancer in response to image pre-processing. Phys Med 61:44–51. https://doi.org/10.1016/j.ejmp.2019.04.009
Morais M, Pinto DM, Machado JC, Carneiro S (2022) ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review. Eur J Surg Oncol 48 (1):218–227. https://doi.org/10.1016/j.ejso.2021.08.034
Bedin C, Crotti S, D'Angelo E, D'Aronco S, Pucciarelli S, Agostini M (2020) Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy. Curr Med Chem 27 (25):4274–4294. https://doi.org/10.2174/0929867326666190507084839
Acknowledgments
The authors thank Joanne Chin, MFA, ELS, for editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
El Homsi, M., Bane, O., Fauveau, V. et al. Prediction of locally advanced rectal cancer response to neoadjuvant chemoradiation therapy using volumetric multiparametric MRI-based radiomics. Abdom Radiol 49, 791–800 (2024). https://doi.org/10.1007/s00261-023-04128-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-023-04128-0